Medical Research News

RSS

Masonic Cancer Center receives five-year program project research grants from NCI

Two of the University of Minnesota Masonic Cancer Center's leading physician-scientists on research and treatment of cancers of the blood and bone marrow Philip McGlave, M.D., and Jeffrey Miller, M.D., have received renewed five-year program project research grants totaling almost $26 million from the National Cancer Institute (NCI).

23 Sep 2010

Genomic imprinting can influence carrier's selfish or altruistic behavior

If you are more inclined to love thyself than thy neighbor, it could be your mother's fault. Those are the findings of Francisco -beda, assistant professor of ecology and evolutionary biology at the University of Tennessee, Knoxville.-beda, along with fellow evolutionary biologist Andy Gardner from Oxford University, examined the impact that genomic imprinting has on the carrier's selfish or altruistic behavior.

23 Sep 2010

Nerve inflammation may cause postsurgical neuropathies: Study

A new Mayo Clinic study found that nerve inflammation may cause the pain, numbness and weakness following surgical procedures that is known as postsurgical neuropathy. The development of postsurgical neuropathies is typically attributed to compression or stretching of nerves during surgery. This new research shows that, in some cases, the neuropathy is actually caused by the immune system attacking the nerves and is potentially treatable with immunosuppressive drugs.

23 Sep 2010

Scientists develop humanized mouse model to study typhoid fever

Better treatments and prevention for typhoid fever may emerge from a laboratory model that has just been developed for the disease. The model is based on transplanting human immune stem cells from umbilical cord blood into mice that are susceptible to infections.

23 Sep 2010

Evotec AG collaborates with Almirall for ion channel validation in respiratory diseases

Evotec AG today announced that it has entered into a collaboration with Almirall S.A. to identify small molecule modulators of an ion channel target, selected by Almirall, involved in respiratory diseases.

23 Sep 2010

Scientists create human liver cells using stem cells

Emerging Healthcare Solutions President and CEO Cindy Morrissey said Tuesday that a recent study at the University of Cambridge seems to indicate that realistic stem cell therapies to replace diseased or damaged tissues may be closer than ever.

23 Sep 2010

Study shows physical and mental health benefits of sports participation in adolescents

Taking part in sports is good all round for young teens: physically, socially, and mentally, according to a new study by Dr. Keith Zullig and Rebecca White from West Virginia University in the US. Their research shows that middle-school teenagers who are physically active and play on sports teams are more satisfied with their life and feel healthier. Zullig and White's paper is published online in Springer's journal Applied Research in Quality of Life.

22 Sep 2010

Scientists develop new therapy for treatment of skin, lung cancer

Scientists at the University of Granada have developed a new therapy for the treatment of skin and lung cancer. This therapy involves the use of a suicide coliphage-gene (gene E) that can induce death to cells transfected with it.. Their studies have demostrated that this technique is not only effective in vitro (using tumour cell cultures), but also in vivo through the use of experimental animals in which tumours were induced.

22 Sep 2010

NIDA awards GeneGo SBIR grant to develop integrated systems biology platform for nicotine addiction research

GeneGo, Inc., the leading systems biology company, today announced that it has been awarded a grant from the National Institute on Drug Abuse to develop an integrated systems biology platform for research into the causes and treatment of tobacco dependence, nicotine addiction, smoking cessation and tobacco/nicotine withdrawal.

22 Sep 2010

G-CSF compound may activate virus, increases risk of infection: Research

Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute may spur debate about the risks associated with administering a specific compound in some forms of bone-marrow transplantation. The research is published in the current edition of Cell Host and Microbe.

22 Sep 2010

Researchers investigate performance levels of resident and staff physicians

Research on the quality of US resident physician performance levels has often been limited by lack of a comparison group or strict focus on specific diseases and geographical areas. In order to gain insight on differences in quality of care provided by resident physicians versus staff physicians, Boston Medical Center and Palo Alto Medical Foundation researchers investigated performance of physicians in 33,900 hospital-based outpatient visits throughout the US.

22 Sep 2010

Study finds no benefit from self-management counseling in patients with heart failure

Patients with mild to moderate heart failure who received educational materials and self-management counseling in an attempt to improve adherence to medical advice did not have a reduced rate of death or hospitalization compared to patients who received educational materials alone, according to a study in the September 22/29 issue of JAMA.

22 Sep 2010

Researchers receive $634,000 grant to study environmental factors, MS progression

A $634,000 grant from the Department of Defense is allowing researchers at the University at Buffalo to investigate a trio of environmental factors and their influence on the progression of multiple sclerosis.

22 Sep 2010

Shrink Nanotechnologies leases laboratory space inside TechPortal

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has leased laboratory space (the "NanoShrink Lab") inside the TechPortal, an innovative and brand new technology facilitator center for commercial bioscience research companies which are in most cases based on University of California, Irvine research.

22 Sep 2010

UC researcher receives NIDA’s Avant-Garde Award for cocaine addiction research

A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.

22 Sep 2010

NIDA's Avant-Garde Awards support novel approaches for treating tobacco and cocaine addiction

A potential immunotherapy, a new gene therapy, an enzyme inhibitor, and a compound originally isolated from a Chinese herb are among the latest approaches scientists are proposing to treat addiction.

22 Sep 2010

Dr. Shlomo Melmed awarded 9th Endocrine Regulation Prize of the Fondation Ipsen

The international jury under the presidency of Professor Iain Robinson (National Institute for Medical Research, London, UK) awarded today the 9th Endocrine Regulation Prize of the Fondation Ipsen (20.000€) to Dr. Shlomo Melmed (Cedars-Sinai Medical Center, Los Angeles, USA) during the annual congress of the ENEA (European NeuroEndocrine Association) in Liège (Belgium), for his translational approach to endocrinology. Shlomo Melmed is an internationally recognized endocrinologist and an authority on pituitary medicine.

22 Sep 2010

Synthetic lethality boosts effectiveness of molecularly targeted therapies against tumors

Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.

22 Sep 2010

Zyxin protein is critical to maintain and repair internal framework

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell.

22 Sep 2010

New findings could impact diagnosis and treatment of ADHD and alcoholism

Impulsive behaviour can be improved with training and the improvement is marked by specific brain changes, according to a new Queen's University study.

22 Sep 2010

Medical Research News

Masonic Cancer Center receives five-year program project research grants from NCI

Genomic imprinting can influence carrier's selfish or altruistic behavior

Nerve inflammation may cause postsurgical neuropathies: Study

Scientists develop humanized mouse model to study typhoid fever

Evotec AG collaborates with Almirall for ion channel validation in respiratory diseases

Scientists create human liver cells using stem cells

Study shows physical and mental health benefits of sports participation in adolescents

Scientists develop new therapy for treatment of skin, lung cancer

NIDA awards GeneGo SBIR grant to develop integrated systems biology platform for nicotine addiction research

G-CSF compound may activate virus, increases risk of infection: Research

Researchers investigate performance levels of resident and staff physicians

Study finds no benefit from self-management counseling in patients with heart failure

Researchers receive $634,000 grant to study environmental factors, MS progression

Shrink Nanotechnologies leases laboratory space inside TechPortal

UC researcher receives NIDA’s Avant-Garde Award for cocaine addiction research

NIDA's Avant-Garde Awards support novel approaches for treating tobacco and cocaine addiction

Dr. Shlomo Melmed awarded 9th Endocrine Regulation Prize of the Fondation Ipsen

Synthetic lethality boosts effectiveness of molecularly targeted therapies against tumors

Zyxin protein is critical to maintain and repair internal framework

New findings could impact diagnosis and treatment of ADHD and alcoholism

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News